CHADWICK NABORS: Open Payments
NPI 1184252389 · ASHEBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,452 in 81 payments from 22 companies in 2025. Trend: 2023 $0 · 2024 $485 · 2025 $1,452
Food & beverage: $1,452
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $386 |
| ABBVIE INC. | 13 | $208 |
| Lilly USA, LLC | 10 | $150 |
| AstraZeneca Pharmaceuticals LP | 8 | $145 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $55 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $53 |
| Amgen Inc. | 3 | $46 |
| Esperion Therapeutics, Inc. | 2 | $45 |
Products named: Wegovy, Ozempic, MOUNJARO, VRAYLAR, REXULTI, UBRELVY, Kerendia, CAPLYTA.
Industry payments across NC — which companies pay providers there.
